JX Advanced Metals
5016
Mitsubishi UFJ Financial Group
8306
Metaplanet
3350
4
Zensho Holdings
7550
5
Nippon Telegraph & Telephone
9432
JP Stock MarketDetailed Quotes
2160 GNI Group
- 2341
- +16+0.69%
20min DelayNot Open Mar 21 15:30 JST
117.57BMarket Cap110.69P/E (Static)
2426High2341Low2.13MVolume2390Open2325Pre Close5.06BTurnover397052wk High4.50%Turnover Ratio50.22MShares153752wk Low21.15EPS TTM110.75BFloat Cap4070Historical High110.69P/E (Static)47.31MShs Float13Historical Low21.15EPS LYR3.66%Amplitude--Dividend TTM3.22P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees867
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Thomas Eastling
- Director
- --
- Ryosuke Matsui
- Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Zhang Ping
- Independent Director
- --
- Hideaki Sashiwa
- Independent Director
- --